230 related articles for article (PubMed ID: 34880105)
1. Inhibition of H3K27me3 Demethylases Promotes Plasmablast Formation.
Kania AK; Guo M; Scharer CD; Boss JM
Immunohorizons; 2021 Dec; 5(12):918-930. PubMed ID: 34880105
[TBL] [Abstract][Full Text] [Related]
2. EZH2, JMJD3, and UTX epigenetically regulate hepatic plasticity inducing retro-differentiation and proliferation of liver cells.
Pediconi N; Salerno D; Lupacchini L; Angrisani A; Peruzzi G; De Smaele E; Levrero M; Belloni L
Cell Death Dis; 2019 Jul; 10(7):518. PubMed ID: 31285428
[TBL] [Abstract][Full Text] [Related]
3. H3K27me3 demethylases regulate in vitro chondrogenesis and chondrocyte activity in osteoarthritis.
Yapp C; Carr AJ; Price A; Oppermann U; Snelling SJ
Arthritis Res Ther; 2016 Jul; 18(1):158. PubMed ID: 27388528
[TBL] [Abstract][Full Text] [Related]
4. H3K27me3 Demethylase UTX Restrains Plasma Cell Formation.
Kania AK; Price MJ; George-Alexander LE; Patterson DG; Hicks SL; Scharer CD; Boss JM
J Immunol; 2022 Apr; 208(8):1873-1885. PubMed ID: 35346967
[TBL] [Abstract][Full Text] [Related]
5. Effects of GSK-J4 on JMJD3 Histone Demethylase in Mouse Prostate Cancer Xenografts.
Sanchez A; Penault-Llorca F; Bignon YJ; Guy L; Bernard-Gallon D
Cancer Genomics Proteomics; 2022; 19(3):339-349. PubMed ID: 35430567
[TBL] [Abstract][Full Text] [Related]
6. The histone demethylase inhibitor GSK-J4 limits inflammation through the induction of a tolerogenic phenotype on DCs.
Doñas C; Carrasco M; Fritz M; Prado C; Tejón G; Osorio-Barrios F; Manríquez V; Reyes P; Pacheco R; Bono MR; Loyola A; Rosemblatt M
J Autoimmun; 2016 Dec; 75():105-117. PubMed ID: 27528513
[TBL] [Abstract][Full Text] [Related]
7. GSK-J4: An H3K27 histone demethylase inhibitor, as a potential anti-cancer agent.
Dalpatraj N; Naik A; Thakur N
Int J Cancer; 2023 Sep; 153(6):1130-1138. PubMed ID: 37165737
[TBL] [Abstract][Full Text] [Related]
8. Targeted inhibition of histone H3K27 demethylation is effective in high-risk neuroblastoma.
Lochmann TL; Powell KM; Ham J; Floros KV; Heisey DAR; Kurupi RIJ; Calbert ML; Ghotra MS; Greninger P; Dozmorov M; Gowda M; Souers AJ; Reynolds CP; Benes CH; Faber AC
Sci Transl Med; 2018 May; 10(441):. PubMed ID: 29769286
[TBL] [Abstract][Full Text] [Related]
9. Transcriptomic Profiling and H3K27me3 Distribution Reveal Both Demethylase-Dependent and Independent Regulation of Developmental Gene Transcription in Cell Differentiation.
Kang SC; Kim SK; Chai JC; Kim SH; Won KJ; Lee YS; Jung KH; Chai YG
PLoS One; 2015; 10(8):e0135276. PubMed ID: 26263556
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia.
Li Y; Zhang M; Sheng M; Zhang P; Chen Z; Xing W; Bai J; Cheng T; Yang FC; Zhou Y
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1065-1077. PubMed ID: 29594337
[TBL] [Abstract][Full Text] [Related]
11. Histone demethylase UTX is a therapeutic target for diabetic kidney disease.
Chen H; Huang Y; Zhu X; Liu C; Yuan Y; Su H; Zhang C; Liu C; Xiong M; Qu Y; Yun P; Zheng L; Huang K
J Physiol; 2019 Mar; 597(6):1643-1660. PubMed ID: 30516825
[TBL] [Abstract][Full Text] [Related]
12. Histone H3 Lysine 27 demethylases Jmjd3 and Utx are required for T-cell differentiation.
Manna S; Kim JK; Baugé C; Cam M; Zhao Y; Shetty J; Vacchio MS; Castro E; Tran B; Tessarollo L; Bosselut R
Nat Commun; 2015 Sep; 6():8152. PubMed ID: 26328764
[TBL] [Abstract][Full Text] [Related]
13. Histone H3K27me3 demethylases regulate human Th17 cell development and effector functions by impacting on metabolism.
Cribbs AP; Terlecki-Zaniewicz S; Philpott M; Baardman J; Ahern D; Lindow M; Obad S; Oerum H; Sampey B; Mander PK; Penn H; Wordsworth P; Bowness P; de Winther M; Prinjha RK; Feldmann M; Oppermann U
Proc Natl Acad Sci U S A; 2020 Mar; 117(11):6056-6066. PubMed ID: 32123118
[TBL] [Abstract][Full Text] [Related]
14. Elevating H3K27me3 level sensitizes colorectal cancer to oxaliplatin.
Wang Q; Chen X; Jiang Y; Liu S; Liu H; Sun X; Zhang H; Liu Z; Tao Y; Li C; Hu Y; Liu D; Ye D; Liu Y; Wang M; Zhang X
J Mol Cell Biol; 2020 Feb; 12(2):125-137. PubMed ID: 31065671
[TBL] [Abstract][Full Text] [Related]
15. Low HOX gene expression in PML-RARα-positive leukemia results from suppressed histone demethylation.
Rejlova K; Musilova A; Kramarzova KS; Zaliova M; Fiser K; Alberich-Jorda M; Trka J; Starkova J
Epigenetics; 2018; 13(1):73-84. PubMed ID: 29224413
[TBL] [Abstract][Full Text] [Related]
16. H3K27me3 demethylase UTX regulates the differentiation of a subset of bipolar cells in the mouse retina.
Umutoni D; Iwagawa T; Baba Y; Tsuhako A; Honda H; Aihara M; Watanabe S
Genes Cells; 2020 Jun; 25(6):402-412. PubMed ID: 32215989
[TBL] [Abstract][Full Text] [Related]
17. Histone demethylase JMJD3 protects against renal fibrosis by suppressing TGFβ and Notch signaling and preserving PTEN expression.
Yu C; Xiong C; Tang J; Hou X; Liu N; Bayliss G; Zhuang S
Theranostics; 2021; 11(6):2706-2721. PubMed ID: 33456568
[No Abstract] [Full Text] [Related]
18. Histone demethylase JMJD3 regulates fibroblast-like synoviocyte-mediated proliferation and joint destruction in rheumatoid arthritis.
Jia W; Wu W; Yang D; Xiao C; Su Z; Huang Z; Li Z; Qin M; Huang M; Liu S; Long F; Mao J; Liu X; Zhu YZ
FASEB J; 2018 Jul; 32(7):4031-4042. PubMed ID: 29481307
[TBL] [Abstract][Full Text] [Related]
19. Jumonji domain containing-3 (JMJD3) inhibition attenuates IL-1β-induced chondrocytes damage in vitro and protects osteoarthritis cartilage in vivo.
Jun Z; Xinmeng J; Yue L; Zhi W; Yan Z; Tieyi Y; Jiangan T
Inflamm Res; 2020 Jul; 69(7):657-666. PubMed ID: 32394143
[TBL] [Abstract][Full Text] [Related]
20. Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases.
Hong S; Cho YW; Yu LR; Yu H; Veenstra TD; Ge K
Proc Natl Acad Sci U S A; 2007 Nov; 104(47):18439-44. PubMed ID: 18003914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
